Actively Recruiting
Developing an AI Pharmacy Chatbot for the Population of Hong Kong
Led by The University of Hong Kong · Updated on 2025-06-25
280
Participants Needed
2
Research Sites
73 weeks
Total Duration
On this page
Sponsors
T
The University of Hong Kong
Lead Sponsor
L
Laboratory of Data Discovery for Health
Collaborating Sponsor
AI-Summary
What this Trial Is About
The primary objective of this study is to is to develop a conversational AI service (chatbot) in Hong Kong to assist patients and caregivers with inquires related to Hospital Authority (HA)-prescribed medications, and to evaluate its effectiveness in answering medication-related questions. The main questions it aims to answer are: 1. How satisfied are the patients and caregivers with this pharmacy chatbot? 2. How will the pharmacy chatbot impact eligible patients or caregivers on their (or the patient they are caring for) medication adherence, knowledge, and the consultation time with HA pharmacists? There will be an intervention group and a control group: 1. The intervention group will be invited to use the AI Pharmacy Chatbot online for 7 days through WhatsApp, a commonly used social media platform in Hong Kong. They can inquire about their medications prescribed under HA and get instant, validated answers from the chatbot. 2. The control group will not use the chatbot during the intervention period. To evaluate the chatbot's usability, researchers will measure patient satisfaction through usability questionnaires issued to the intervention group after their intervention period. Differences in medication adherence, medication knowledge, and HA pharmacist consultation time will also be measured between the intervention and control groups after the intervention period, to determine the chatbot's impact.
CONDITIONS
Official Title
Developing an AI Pharmacy Chatbot for the Population of Hong Kong
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 years or older diagnosed with hyperglycaemia, hypertension, or hyperlipidaemia and currently receiving medication prescribed by the Hospital Authority in Hong Kong
- Caregivers aged 18 years or older for patients described above
You will not qualify if you...
- No exclusion criteria beyond not meeting the inclusion criteria
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Laboratory of Data Discovery for Health
Hong Kong, Hong Kong
Actively Recruiting
2
The University of Hong Kong
Hong Kong, Hong Kong
Actively Recruiting
Research Team
J
Joseph Wu, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here